Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Anti-PRDM1 / MEL1 Antibody
| Applications | IHC, WB |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat, Dog, Pig, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-PRDM1 / MEL1 Antibody: Peptide with sequence C-DISDNADRLEDVED, from the internal region of the protein sequence according to NP_001189.2; NP_878911.1. |
Goat Polyclonal Antibody against TBL1X / TBL1XR1
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence SASDGSVCVLDLRK, from the C Terminus of the protein sequence according to NP_005638.1; NP_078941.2. |
Goat Anti-HMGA1 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-LASKQEKDGTEK, from the internal region of the protein sequence according to NP_665906.1; NP_665908.1; NP_002122.1; NP_665909.1; NP_665912.1; NP_665910.1. |
TCF7 (617-631) goat polyclonal antibody, Aff - Purified
| Applications | IHC |
| Reactivities | Bat, Canine, Equine, Hamster, Human, Mouse, Porcine, Rat |
| Immunogen | Synthetic peptide from positions 617-631 of human TCF1 (NP_000536.5) |
Goat Polyclonal Antibody against PAX3
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence TTLAGAVPRMM-C, from the N Terminus of the protein sequence according to NP_000429.2; NP_039230.1; NP_852122;.1 NP_852123.1; NP_852124.1; NP_852125.1; NP_852126.1. |
Goat Anti-PIAS2 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence KEAMKVSSQPCTKIE, from the internal region of the protein sequence according to NP_775298.1; NP_004662.2. |
Goat Anti-AP-2 gamma Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NKTLEKMEKHRK, from the C Terminus of the protein sequence according to NP_003213.1. |
Goat Anti-DMRT2 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KRPSSAITRVSQ, from the C Terminus of the protein sequence according to NP_006548.1; NP_870987.2. |
BRG1 (SMARCA4) (2-14) goat polyclonal antibody, Aff - Purified
| Applications | IHC |
| Reactivities | Bat, Canine, Chicken, Equine, Hamster, Human, Monkey, Mouse, Porcine, Rabbit, Rat |
| Immunogen | Synthetic peptide from from the N-terminus ( aa 2-14) of Human SMARCA4 / BRG1 (NP_001122321.1; NP_003063.2; NP_001122317.1; NP_001122318.1; NP_001122319.1; NP_001122320.1) |
Goat Polyclonal Antibody against FOXN1
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-SVYLSPSSKPVALA, from the C Terminus of the protein sequence according to NP_003584. |
Goat Polyclonal Antibody against RNF213
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KTAAVLKWNRE, from the C Terminus of the protein sequence according to NP_065965.3. |
Goat Anti-MSX1 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence TSLPLGVKVEDS-C, from the N Terminus of the protein sequence according to NP_002439.1. |
Goat Anti-EWS / EWSR1 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TSYDQSSYSQQNTYG, from the internal region of the protein sequence according to NP_053733.1; NP_005234.1. |
Goat Anti-HMG20A Antibody
| Applications | IHC |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-ATVREVVNRLDR, from the C Terminus of the protein sequence according to NP_060670.1. |
Anti-Human FGF-10 Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human FGF-10 |
Active filters
Applications
- IHC
Antibody Hosts
- Goat
Isotypes
- IgG
Families
- Transcription Factors
Filter by
Category
Target Symbol
- MSX1 (2)
- MYB (2)
- APEX1 (1)
- AR (1)
- COPS2 (1)
- CREB3L4 (1)
- DMRT2 (1)
- EDF1 (1)
- EWSR1 (1)
- FGF10 (1)
- FOXA2 (1)
- FOXL2 (1)
- FOXN1 (1)
- FOXP2 (1)
- FOXP3 (1)
- GABPB1 (1)
- GATA3 (1)
- HMG20A (1)
- HMGA1 (1)
- HNF4A (1)
- HOXB6 (1)
- IRF6 (1)
- KLF1 (1)
- PARD6A (1)
- PAX3 (1)
- PIAS2 (1)
- PRDM1 (1)
- PTTG1 (1)
- RAB25 (1)
- RNF213 (1)
- SMARCA4 (1)
- SMARCE1 (1)
- SPI1 (1)
- STAT3 (1)
- TBL1X (1)
- TCF7 (1)
- TFAP2C (1)
- THRA (1)
- TNF (1)
- TRIM28 (1)
- VPS25 (1)
Reactivities
Clonalities
Conjugates
Pathways
- Pathways in cancer (6)
- Acute myeloid leukemia (3)
- Prostate cancer (3)
- Adipocytokine signaling pathway (2)
- Endocytosis (2)
- Jak-STAT signaling pathway (2)
- MAPK signaling pathway (2)
- Maturity onset diabetes of the young (2)
- Melanogenesis (2)
- Oocyte meiosis (2)
- Wnt signaling pathway (2)
- Adherens junction (1)
- Allograft rejection (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Apoptosis (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Asthma (1)
- Basal cell carcinoma (1)
- Base excision repair (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Colorectal cancer (1)
- Cytokine-cytokine receptor interaction (1)
- Dilated cardiomyopathy (1)
- Endometrial cancer (1)
- Fc epsilon RI signaling pathway (1)
- Graft-versus-host disease (1)
- Hematopoietic cell lineage (1)
- Huntington's disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Neuroactive ligand-receptor interaction (1)
- Pancreatic cancer (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of actin cytoskeleton (1)
- Small cell lung cancer (1)
- Systemic lupus erythematosus (1)
- T cell receptor signaling pathway (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Tight junction (1)
- Toll-like receptor signaling pathway (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- Ubiquitin mediated proteolysis (1)